BioSpace News Archive

The Accreditation Council for Medical Affairs, an organization exclusively dedicated to raising industry standards surrounding medical affairs has announced a newly accredited professional certification called the Prior Authorization Certified Specialist program.

Drawing on NORD’s expertise in capacity-building and nonprofit management during crises, the new program will support rare disease patient organizations through education, training and resources

‘Planning for the Next Normal at Work’ provides guidance around health considerations for returning to the workplace [21-May-2020] OAKLAND, Calif. , May 21, 2020 /PRNewswire/ -- Kaiser Permanente has released a playbook, “Planning for the Next Normal at Work,” to guide employers and businesses through health considerations they will need to address as they safeguard w

Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that it has completed the registration process and affixed the CE mark (Conformité Européene) to its rapid REVEALCOVID-19™ Total Antibody Test.

Atrion Corporation announced that its Board of Directors declared a quarterly dividend of $1.55 per share on its outstanding shares of Common Stock.

Philadelphia College of Osteopathic Medicine was recently granted a full, 10- year continuing accreditation for its osteopathic medical program from its accrediting institution.

Castlight Health, Inc. announced a partnership with the New York State Department of Health to launch a statewide directory of COVID-19 test sites.

Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order from the Supreme Court of British Columbia approving the previously announced p

PDL BioPharma, Inc. (“PDL” or the “Company”) (Nasdaq: PDLI) announces that it has completed its previously announced distribution of all of the Company’s 13,333,334 shares of common stock of Evofem Biosciences, Inc. (“Evofem”) (Nasdaq: EVFM), which represented approximately 26.7% of the outstanding shares of Evofem common stock a

Equillium, Inc., a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders, announced that Bruce Steel, Equillium’s chief executive officer and Krishna Polu, M.D., chief medical officer, will present at Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020.